Advertisement
Screener

AIM IMMUNOTECH INC. (AIM) Operating Income

AIM IMMUNOTECH INC. Operating Income

AIM IMMUNOTECH INC. (AIM) reported Operating Income of -$3.51 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement

us-gaap:OperatingIncomeLoss · last filed 2026-08-07

  • AIM IMMUNOTECH INC. operating income (loss) for the quarter ending 2026-06-30 was -$3.51M.
  • AIM IMMUNOTECH INC. operating income (loss) for the quarter ending 2026-03-31 was -$2.23M.
  • AIM IMMUNOTECH INC. operating income (loss) for the quarter ending 2025-12-31 was -$2.95M.
  • AIM IMMUNOTECH INC. operating income (loss) for the quarter ending 2025-09-30 was -$2.45M.
  • AIM IMMUNOTECH INC. operating income (loss) for fiscal 2025 was -$11.66M.
  • AIM IMMUNOTECH INC. operating income (loss) for fiscal 2024 was -$19.77M.
  • AIM IMMUNOTECH INC. operating income (loss) for fiscal 2023 was -$31.92M.
  • AIM IMMUNOTECH INC. operating income (loss) for fiscal 2022 was -$19.92M.
Period endOperating Income (Loss) 3 monthOperating Income (Loss) 6 monthOperating Income (Loss) 9 monthOperating Income (Loss) 12 month
2026-06-30-$3.51M
10-Q · filed 2026-08-07
-$5.74M
10-Q · filed 2026-08-07
-$8.69M
derived: sum of 3 quarters · filed 2026-08-07
-$11.14M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$2.23M
10-Q · filed 2026-05-15
-$5.18M
derived: sum of 2 quarters · filed 2026-05-15
-$7.63M
derived: sum of 3 quarters · filed 2026-05-15
-$10.27M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31-$2.95M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$5.40M
derived: sum of 2 quarters · filed 2026-03-27
-$8.04M
derived: sum of 3 quarters · filed 2026-08-07
-$11.66M
10-K · filed 2026-03-27
2025-09-30-$2.45M
10-Q · filed 2025-11-17
-$5.09M
derived: sum of 2 quarters · filed 2026-08-07
-$8.71M
10-Q · filed 2025-11-17
-$14.57M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30-$2.65M
10-Q · filed 2026-08-07
-$6.26M
10-Q · filed 2026-08-07
-$12.12M
derived: sum of 3 quarters · filed 2026-08-07
-$16.61M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$3.62M
10-Q · filed 2026-05-15
-$9.47M
derived: sum of 2 quarters · filed 2026-05-15
-$13.96M
derived: sum of 3 quarters · filed 2026-05-15
-$17.66M
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31-$5.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27
-$10.34M
derived: sum of 2 quarters · filed 2026-03-27
-$14.04M
derived: sum of 3 quarters · filed 2026-03-27
-$19.77M
10-K · filed 2026-03-27
2024-09-30-$4.49M
10-Q · filed 2025-11-17
-$8.18M
derived: sum of 2 quarters · filed 2025-11-17
-$13.92M
10-Q · filed 2025-11-17
-$27.92M
derived: sum of 4 quarters · filed 2025-11-17
2024-06-30-$3.69M
10-Q · filed 2025-08-14
-$9.43M
10-Q · filed 2025-08-14
-$23.43M
derived: sum of 3 quarters · filed 2025-08-14
-$31.59M
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31-$5.73M
10-Q · filed 2025-05-15
-$19.74M
derived: sum of 2 quarters · filed 2025-05-15
-$27.89M
derived: sum of 3 quarters · filed 2025-05-15
-$33.36M
derived: sum of 4 quarters · filed 2025-05-15
2023-12-31-$14.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27
-$22.16M
derived: sum of 2 quarters · filed 2025-03-27
-$27.62M
derived: sum of 3 quarters · filed 2025-03-27
-$31.92M
10-K · filed 2025-03-27
2023-09-30-$8.16M
10-Q · filed 2024-11-14
-$13.62M
derived: sum of 2 quarters · filed 2024-11-14
-$17.91M
10-Q · filed 2024-11-14
-$23.47M
derived: sum of 4 quarters · filed 2024-11-14
2023-06-30-$5.46M
10-Q · filed 2024-08-14
-$9.76M
10-Q · filed 2024-08-14
-$15.31M
derived: sum of 3 quarters · filed 2024-08-14
-$21.83M
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31-$4.29M
10-Q · filed 2024-05-15
-$9.85M
derived: sum of 2 quarters · filed 2024-05-15
-$16.37M
derived: sum of 3 quarters · filed 2024-05-15
-$21.07M
derived: sum of 4 quarters · filed 2024-05-15
2022-12-31-$5.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01
-$12.08M
derived: sum of 2 quarters · filed 2024-04-01
-$16.77M
derived: sum of 3 quarters · filed 2024-04-01
-$19.92M
10-K · filed 2024-04-01
2022-09-30-$6.52M
10-Q · filed 2023-11-14
-$11.22M
derived: sum of 2 quarters · filed 2023-11-14
-$14.37M
10-Q · filed 2023-11-14
-$21.81M
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$4.70M
10-Q · filed 2023-08-14
-$7.85M
10-Q · filed 2023-08-14
-$15.29M
derived: sum of 3 quarters · filed 2023-08-14
-$19.22M
derived: sum of 4 quarters · filed 2023-08-14
2022-03-31-$3.15M
10-Q · filed 2023-05-15
-$10.60M
derived: sum of 2 quarters · filed 2023-05-15
-$14.53M
derived: sum of 3 quarters · filed 2023-05-15
-$18.24M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$7.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31
-$11.37M
derived: sum of 2 quarters · filed 2023-03-31
-$15.09M
derived: sum of 3 quarters · filed 2023-03-31
-$18.84M
10-K · filed 2023-03-31
2021-09-30-$3.93M
10-Q · filed 2022-11-14
-$7.65M
derived: sum of 2 quarters · filed 2022-11-14
-$11.39M
10-Q · filed 2022-11-14
-$16.54M
derived: sum of 4 quarters · filed 2022-11-14
2021-06-30-$3.72M
10-Q · filed 2022-08-15
-$7.46M
10-Q · filed 2022-08-15
-$12.61M
derived: sum of 3 quarters · filed 2022-08-15
-$15.97M
derived: sum of 4 quarters · filed 2022-08-15
2021-03-31-$3.75M
10-Q · filed 2022-05-13
-$8.89M
derived: sum of 2 quarters · filed 2022-05-13
-$12.25M
derived: sum of 3 quarters · filed 2022-05-13
-$15.59M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31-$5.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31
-$8.51M
derived: sum of 2 quarters · filed 2022-03-31
-$11.85M
derived: sum of 3 quarters · filed 2022-03-31
-$15.15M
10-K · filed 2022-03-31
2020-09-30-$3.35M
10-Q · filed 2021-11-15
-$6.70M
derived: sum of 2 quarters · filed 2021-11-15
-$10.00M
10-Q · filed 2021-11-15
-$13.11M
derived: sum of 4 quarters · filed 2021-11-15
2020-06-30-$3.34M
10-Q · filed 2021-08-16
-$6.65M
10-Q · filed 2021-08-16
-$9.75M
derived: sum of 3 quarters · filed 2021-08-16
-$12.96M
derived: sum of 4 quarters · filed 2021-08-16
2020-03-31-$3.33M
10-Q · filed 2021-05-17
-$6.41M
derived: sum of 2 quarters · filed 2021-05-17
-$9.62M
derived: sum of 3 quarters · filed 2021-05-17
-$12.84M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$3.09M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31
-$6.29M
derived: sum of 2 quarters · filed 2021-03-31
-$9.52M
derived: sum of 3 quarters · filed 2021-03-31
-$12.44M
10-K · filed 2021-03-31
2019-09-30-$3.21M
10-Q · filed 2020-11-12
-$6.43M
derived: sum of 2 quarters · filed 2020-11-12
-$9.36M
10-Q · filed 2020-11-12
-$12.02M
derived: sum of 4 quarters · filed 2020-11-12
2019-06-30-$3.22M
10-Q · filed 2020-08-14
-$6.15M
10-Q · filed 2020-08-14
-$8.81M
derived: sum of 3 quarters · filed 2020-08-14
-$11.85M
derived: sum of 4 quarters · filed 2020-08-14
2019-03-31-$2.93M
10-Q · filed 2020-05-14
-$5.59M
derived: sum of 2 quarters · filed 2020-05-14
-$8.63M
derived: sum of 3 quarters · filed 2020-05-14
-$11.85M
derived: sum of 4 quarters · filed 2020-05-14
2018-12-31-$2.66M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30
-$5.70M
derived: sum of 2 quarters · filed 2020-03-30
-$8.93M
derived: sum of 3 quarters · filed 2020-03-30
-$11.50M
10-K · filed 2020-03-30
2018-09-30-$3.04M
10-Q · filed 2019-11-14
-$6.26M
derived: sum of 2 quarters · filed 2019-11-14
-$8.84M
10-Q · filed 2019-11-14
-$11.63M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$3.23M
10-Q · filed 2019-08-14
-$5.80M
10-Q · filed 2019-08-14
-$8.59M
derived: sum of 3 quarters · filed 2019-08-14
-$11.24M
derived: sum of 4 quarters · filed 2019-08-14
2018-03-31-$2.57M
10-Q · filed 2019-05-15
-$5.36M
derived: sum of 2 quarters · filed 2019-05-15
-$8.02M
derived: sum of 3 quarters · filed 2019-05-15
-$10.74M
derived: sum of 4 quarters · filed 2019-05-15
2017-12-31-$2.79M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01
-$5.45M
derived: sum of 2 quarters · filed 2019-04-01
-$8.18M
derived: sum of 3 quarters · filed 2019-04-01
-$11.42M
10-K · filed 2019-04-01
2017-09-30-$2.65M
10-Q · filed 2018-11-14
-$5.38M
derived: sum of 2 quarters · filed 2018-11-14
-$8.62M
10-Q · filed 2018-11-14
-$12.71M
derived: sum of 4 quarters · filed 2018-11-14
2017-06-30-$2.73M
10-Q · filed 2018-08-14
-$5.97M
10-Q · filed 2018-08-14
-$10.06M
derived: sum of 3 quarters · filed 2018-08-14
-$13.28M
derived: sum of 4 quarters · filed 2018-08-14
2017-03-31-$3.24M
10-Q · filed 2018-05-15
-$7.33M
derived: sum of 2 quarters · filed 2018-05-15
-$10.55M
derived: sum of 3 quarters · filed 2018-05-15
-$13.37M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$4.08M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30
-$7.31M
derived: sum of 2 quarters · filed 2018-03-30
-$10.13M
derived: sum of 3 quarters · filed 2018-03-30
-$13.80M
10-K · filed 2018-03-30
2016-09-30-$3.23M
10-Q · filed 2017-11-14
-$6.04M
derived: sum of 2 quarters · filed 2017-11-14
-$9.72M
10-Q · filed 2017-11-14
-$12.56M
derived: sum of 4 quarters · filed 2018-03-30
2016-06-30-$2.81M
10-Q · filed 2017-08-14
-$6.49M
10-Q · filed 2017-08-14
-$9.34M
derived: sum of 3 quarters · filed 2018-03-30
-$13.32M
derived: sum of 4 quarters · filed 2018-03-30
2016-03-31-$3.68M
10-Q · filed 2017-05-15
-$6.52M
derived: sum of 2 quarters · filed 2018-03-30
-$10.51M
derived: sum of 3 quarters · filed 2018-03-30
-$15.41M
derived: sum of 4 quarters · filed 2018-03-30
2015-12-31-$2.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-30
-$6.83M
derived: sum of 2 quarters · filed 2018-03-30
-$11.73M
derived: sum of 3 quarters · filed 2018-03-30
-$16.65M
10-K · filed 2018-03-30
2015-09-30-$3.98M
10-Q · filed 2016-11-14
-$8.88M
derived: sum of 2 quarters · filed 2016-11-14
-$13.81M
10-Q · filed 2016-11-14
-$18.38M
derived: sum of 4 quarters · filed 2017-03-31
2015-06-30-$4.90M
10-Q · filed 2016-08-15
-$9.82M
10-Q · filed 2016-08-15
-$14.40M
derived: sum of 3 quarters · filed 2017-03-31
-$18.73M
derived: sum of 4 quarters · filed 2017-03-31
2015-03-31-$4.92M
10-Q · filed 2016-05-16
-$9.50M
derived: sum of 2 quarters · filed 2017-03-31
-$13.82M
derived: sum of 3 quarters · filed 2017-03-31
-$18.91M
derived: sum of 4 quarters · filed 2017-03-31
2014-12-31-$4.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31
-$8.90M
derived: sum of 2 quarters · filed 2017-03-31
-$13.99M
derived: sum of 3 quarters · filed 2017-03-31
-$19.10M
10-K · filed 2017-03-31
2014-09-30-$4.33M
10-Q · filed 2015-11-16
-$9.41M
derived: sum of 2 quarters · filed 2015-11-16
-$14.53M
10-Q · filed 2015-11-16
-$17.94M
derived: sum of 4 quarters · filed 2016-03-29
2014-06-30-$5.08M
10-Q · filed 2015-08-12
-$10.20M
10-Q · filed 2015-08-12
-$13.61M
derived: sum of 3 quarters · filed 2016-03-29
-$18.07M
derived: sum of 4 quarters · filed 2016-03-29
2014-03-31-$5.11M
10-Q · filed 2015-05-12
-$8.52M
derived: sum of 2 quarters · filed 2016-03-29
-$12.98M
derived: sum of 3 quarters · filed 2016-03-29
-$17.72M
derived: sum of 4 quarters · filed 2016-03-29
2013-12-31-$3.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
-$7.87M
derived: sum of 2 quarters · filed 2016-03-29
-$12.61M
derived: sum of 3 quarters · filed 2016-03-29
-$17.17M
10-K · filed 2016-03-29
2013-09-30-$4.46M
10-Q · filed 2014-11-07
-$9.19M
derived: sum of 2 quarters · filed 2014-11-07
-$13.76M
10-Q · filed 2014-11-07
-$21.75M
derived: sum of 4 quarters · filed 2015-03-19
2013-06-30-$4.73M
10-Q · filed 2014-08-08
-$9.30M
10-Q · filed 2014-08-08
-$17.29M
derived: sum of 3 quarters · filed 2015-03-19
-$22.26M
derived: sum of 4 quarters · filed 2015-03-19
2013-03-31-$4.56M
10-Q · filed 2014-05-09
-$12.56M
derived: sum of 2 quarters · filed 2015-03-19
-$17.52M
derived: sum of 3 quarters · filed 2015-03-19
-$21.16M
derived: sum of 4 quarters · filed 2015-03-19
2012-12-31-$8.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-19
-$12.96M
derived: sum of 2 quarters · filed 2015-03-19
-$16.59M
derived: sum of 3 quarters · filed 2015-03-19
-$20.34M
10-K · filed 2015-03-19
2012-09-30-$4.96M
10-Q · filed 2013-11-08
-$8.60M
derived: sum of 2 quarters · filed 2013-11-08
-$12.35M
10-Q · filed 2013-11-08
-$16.25M
derived: sum of 4 quarters · filed 2014-03-14
2012-06-30-$3.63M
10-Q · filed 2013-08-09
-$7.38M
10-Q · filed 2013-08-09
-$11.28M
derived: sum of 3 quarters · filed 2014-03-14
-$14.84M
derived: sum of 4 quarters · filed 2014-03-14
2012-03-31-$3.75M
10-Q · filed 2013-05-08
-$7.65M
derived: sum of 2 quarters · filed 2014-03-14
-$11.20M
derived: sum of 3 quarters · filed 2014-03-14
-$14.45M
derived: sum of 4 quarters · filed 2014-03-14
2011-12-31-$3.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14
-$7.46M
derived: sum of 2 quarters · filed 2014-03-14
-$10.71M
derived: sum of 3 quarters · filed 2014-03-14
-$14.29M
10-K · filed 2014-03-14
2011-09-30-$3.56M
10-Q · filed 2012-11-02
-$6.80M
derived: sum of 2 quarters · filed 2012-11-02
-$10.39M
10-Q · filed 2012-11-02
-$15.25M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30-$3.25M
10-Q · filed 2012-08-08
-$6.84M
10-Q · filed 2012-08-08
-$11.69M
derived: sum of 3 quarters · filed 2013-03-18
-$15.38M
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31-$3.59M
10-Q · filed 2012-05-07
-$8.44M
derived: sum of 2 quarters · filed 2013-03-18
-$12.13M
derived: sum of 3 quarters · filed 2013-03-18
-$15.90M
derived: sum of 4 quarters · filed 2013-03-18
2010-12-31-$4.85M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
-$8.54M
derived: sum of 2 quarters · filed 2013-03-18
-$12.31M
derived: sum of 3 quarters · filed 2013-03-18
-$16.39M
10-K · filed 2013-03-18
2010-09-30-$3.69M
10-Q · filed 2011-11-09
-$7.46M
derived: sum of 2 quarters · filed 2011-11-09
-$11.53M
10-Q · filed 2011-11-09
2010-06-30-$3.77M
10-Q · filed 2011-08-05
-$7.84M
10-Q · filed 2011-08-05
2009-12-31-$13.26M
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B